|
May 22
|
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
|
|
May 21
|
ATS 2025: GSK strengthens argument for twice-annual depemokimab
|
|
May 19
|
Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio?
|
|
May 19
|
GSK’s Blood-Cancer Treatment Combinations Approved in Japan
|
|
Mar 12
|
The most popular stocks for investors in February
|
|
Mar 11
|
Bear Of The Day: TopBuild (BLD)
|
|
Mar 3
|
Is GSK plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?
|
|
Mar 3
|
GSK Full Year 2024 Earnings: EPS Misses Expectations
|
|
Mar 1
|
Is GSK plc (GSK) The Best Immunology Stock To Buy Now?
|
|
Feb 26
|
Why GSK plc (GSK) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds
|
|
Feb 26
|
The ‘dreadful’ decline of a British drug giant – and why RFK Jr could make it worse
|
|
Feb 23
|
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
|
Feb 21
|
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
|
|
Feb 19
|
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
|
|
Feb 17
|
Trending tickers: TSMC, Tencent, Alibaba, GSK and BAE Systems
|
|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|